Companies Announcing Increase in XRP Holdings within their Reserves, According to Bill Morgan
In a significant shift for the cryptocurrency market, several public companies have started adding XRP to their reserves, joining the ranks of Bitcoin and Ethereum. This trend, which has seen corporate investments in altcoins increase dramatically, has been driven by XRP's unique advantages as a fast, low-cost, and globally transferable digital asset.
The end of the Ripple vs. SEC lawsuit has removed a major roadblock, making it easier for top public companies holding XRP to add it to their balance sheets. This legal clarity has contributed to XRP's increased adoption by corporations, providing a level of regulatory certainty that other cryptocurrencies may not offer.
Among the companies embracing XRP are SBI Holdings, Trident Digital Tech Holdings, Quantum Biopharma Ltd, Worksport Ltd, Nature's Miracle Holding Inc., Wellgistics Health, and Thumzup Media. These firms have acquired XRP often alongside Bitcoin and Ethereum, with holdings ranging from millions to billions of dollars.
The appeal of XRP lies in its speed, low fees, global transfer capabilities, regulatory clarity, strategic value, yield potential, and ecosystem engagement. XRP offers fast transaction finality, enabling rapid cross-border payments, and transactions on the XRP Ledger have minimal costs, making it advantageous for treasury and operational use.
Companies view XRP not only as an investment but as a liquidity and payment infrastructure tool integrated into their business operations. For instance, Nasdaq-listed Wellgistics is deploying XRP-powered payment systems across thousands of pharmacies while holding XRP on its balance sheet. Some companies plan to stake XRP for yield or deepen involvement with Ripple's ecosystem, enhancing the asset’s utility.
Noteworthy examples include SBI Holdings, which holds XRP worth about $10 billion, far exceeding its market value, actively using it for treasury purposes and promoting crypto ETF applications in Japan. Trident Digital Tech plans a $500 million XRP treasury, indicating strong institutional confidence and viewing XRP as a long-term reserve with staking benefits. Nature's Miracle Holding publicly announced a $20 million XRP treasury allocation as validation of its cross-border payment utility.
Worksport Ltd and Quantum Biopharma Ltd are increasing their XRP holdings alongside other digital assets as a hedge against inflation and for liquidity diversification. Quantum Biopharma Ltd has also increased its holdings of Ethereum, Dogecoin, and Solana, indicating a broader diversification strategy.
Companies can put their XRP holdings to work through institutional lending programs, providing liquidity on exchanges, and using platforms like Flare for DeFi/smart contract use, turning XRP from a passive reserve into an active, income-generating asset. Treating Ripple's XRP holdings as formal reserves could potentially tighten XRP supply and boost prices, similar to MicroStrategy's Bitcoin strategy.
With its speed (3-5 second transactions) and low fees (less than $0.01), XRP is ideal for cross-border payments and inflation hedging. This trend reflects a broader corporate adoption pattern, where XRP is moving beyond speculation to become a core strategic asset for treasury management and payment infrastructure in public companies globally.
- Trends in the corporate sector reveal a surge in investments in altcoins, with XRP, Bitcoin, and Ethereum being among the cryptocurrencies added to several public companies' reserves.
- As the Ripple vs. SEC lawsuit comes to a close, top public companies holding XRP can gain regulatory certainty, making it easier to add XRP to their balance sheets and enhance its adoption.
- Some firms, like SBI Holdings and Trident Digital Tech, are not only investing in XRP but also view it as a strategic asset for treasury purposes and long-term appreciation, with holding values ranging from millions to billions of dollars.
- Companies, such as Worksport Ltd and Quantum Biopharma Ltd, are diversifying their crypto investments to hedge against inflation and improve liquidity, with Quantum Biopharma Ltd also increasing its holdings in Ethereum, Dogecoin, and Solana.
